Clinical Study Results
Average amount of ticagrelor in the blood after treatment
(Group 1 and Group 2 combined)
50
doolb
40
eht
30 ni )Lm/gn(
tnuoma
21.9 ng/mL
18.6 ng/mL
20
16.1 ng/mL
egarevA
10.3 ng/mL
10
0
1 hour after 2 hours after 4 hours after 6 hours after
treatment treatment treatment treatment
What medical problems did the participants have during
the study?
This section is a summary of the medical problems the participants had during
the study that the study doctors thought might be related to the study drug. These
medical problems are called “adverse reactions”. An adverse reaction is considered
“serious” when it is life-threatening, causes lasting problems, or requires hospital
care.
Adverse reactions may or may not be caused by the study drug. A lot of research is
needed to know whether a drug causes an adverse reaction.
How many participants had serious adverse reactions?
None of the participants had serious adverse reactions during the study.
How many participants had adverse reactions?
None of participants had adverse reactions during the study.
5